Drug intelligence / Profile preview

Apither bacterial vaccine

Development stage
Unknown
Lead developer
Asac Pharmaceutical Immunology
Modality
Vaccines & Immunotherapeutics
Administration
Sublingual
01

Overview

Apither bacterial vaccine is an individualized, sublingual, inactivated whole-cell bacterial vaccine (autovaccine) developed by Asac Pharmaceutical Immunology. It is formulated as a sublingual suspension containing inactivated bacteria (typically at a concentration of 2.6 billion bacteria/mL) tailored specifically to the patient's pathogen profile. The vaccine is indicated for the prevention of recurrent respiratory tract infections (RTIs) and recurrent urinary tract infections (UTIs). It acts as an immunomodulator, stimulating both the innate and adaptive immune systems—including the induction of specific IgA, IgG, and IgM antibodies and the activation of macrophages and T-helper lymphocytes—to enhance the body's defense against recurrent bacterial infections.

Brand names
ApitherApither bacterial vaccine
Other names
Apither Vacuna BacterianaApither Vacuna Bacteriana Individualizada Sublingual Spray

Beyond the preview

Go deeper on Apither bacterial vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apither bacterial vaccine.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call